RemeGen Co., Ltd. (REGMF)
12.05
0.00 (0.00%)
USD |
OTCM |
Jun 01, 16:00
RemeGen Enterprise Value : 6.696B for June 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ascletis Pharma, Inc. | 1.670B |
| CStone Pharmaceuticals Co. Ltd. | 883.84M |
| InnoCare Pharma Ltd. | 1.970B |
| Adagene, Inc. | 265.44M |
| JW (Cayman) Therapeutics Co. Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 47.37M |
| Revenue (Quarterly) | 94.77M |
| Total Expenses (Quarterly) | 47.40M |
| EPS Diluted (Quarterly) | 0.0847 |
| Earnings Yield | -1.48% |